Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial

Bone marrow‐derived cells contribute to tissue repair, but traffic of hematopoietic stem/progenitor cells (HSPCs) is impaired in diabetes. We therefore tested whether HSPC mobilization with the CXCR4 antagonist plerixafor improved healing of ischemic diabetic wounds. This was a pilot, phase IIa, dou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Bonora, Benedetta Maria, Cappellari, Roberta, Mazzucato, Marta, Rigato, Mauro, Grasso, Marco, Menegolo, Mirko, Bruttocao, Andrea, Avogaro, Angelo, Fadini, Gian Paolo
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2020
Matèries:
Human Clinical Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445026/
https://ncbi.nlm.nih.gov/pubmed/32485785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars